$ORKA 8-K SEC Filings

Filed On	Filing
26 Oct 2026	8-K: Regulation FD Disclosure; Other Events ©2026 Oruka Therapeutics ©2026 ORUKA THERAPEUTICS EVERLAST - B Interim Data ORKA - 001 Phase 2b trial in psoriasis October 26, 2026
24 Aug 2026	8-K: Departure/Election of Directors or Officers; Compensation
10 Aug 2026	8-K: Results of Operations and Financial Condition
04 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
01 Jun 2026	8-K: Other Events
30 Apr 2026	8-K: Results of Operations and Financial Condition; Other Events
27 Apr 2026	8-K: Regulation FD Disclosure; Other Events
11 Dec 2025	8-K: Departure/Election of Directors or Officers; Compensation
22 Sep 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
01 Jul 2025	8-K: Departure/Election of Directors or Officers; Compensation
03 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
05 Feb 2025	8-K: Entry into a Material Definitive Agreement
19 Dec 2024	8-K: Entry into a Material Definitive Agreement
18 Nov 2024	8-K: Submission of Matters to a Vote of Security Holders
14 Nov 2024	8-K: Other Events
04 Oct 2024	8-K: Departure/Election of Directors or Officers; Compensation
13 Sep 2024	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +2 more
05 Sep 2024	8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +9 more
27 Aug 2024	8-K: Other Events
23 Aug 2024	8-K: Submission of Matters to a Vote of Security Holders; Other Events

Comments